The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global 3D Bioprinting for Life Science R&D Market Research Report 2025
Synopsis
3D printing first got widespread public attention in 2013, when it was specifically mentioned by President Obama in his State of the Union Address. 3D printing is a manufacturing process where an object is created with the help of a layer-by-layer material approach. Each layer can be considered a thin horizontal cross-section of the final product. It uses Computer Aided Design (CAD) i.e. a digital blueprint to create rapid prototypes, spare parts and final products. 3D printing uses materials like thermoplastics, plastic composites, metals, alloys, ceramics etc. 3D printing as an end-use manufacturing technology is still not fully developed but it has the potential to transform the conception, manufacturing and logistics processes.
The global 3D Bioprinting for Life Science R&D market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The drug testing market is likely to be the main driver of the 3D Bioprinting for Life Science R&D Market. Since 2011, a group of U.S government agencies have been investing in something known as ‘Human on a chip’ or ‘Body on a chip’. The objective is to create a miniature human organ system that mimics the bodily response to harmful agents, enabling the development of potential therapies. The pharmaceutical industry could use such equipment to test drugs more efficiently due to human stem cells and at a much lower cost. It would also be less risky.
This report aims to provide a comprehensive presentation of the global market for 3D Bioprinting for Life Science R&D, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Bioprinting for Life Science R&D.
Report Scope
The 3D Bioprinting for Life Science R&D market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global 3D Bioprinting for Life Science R&D market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 3D Bioprinting for Life Science R&D companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
EnvisionTEC
Regenovo
Organovo
3D Systems
3D Biotek
Advanced Biomatrix
Digilab
Nano3D Biosciences
Segment by Type
Magnetic 3D Bioprinting
Laser-Assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Segment by Application
Clinical
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 3D Bioprinting for Life Science R&D companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
3D printing first got widespread public attention in 2013, when it was specifically mentioned by President Obama in his State of the Union Address. 3D printing is a manufacturing process where an object is created with the help of a layer-by-layer material approach. Each layer can be considered a thin horizontal cross-section of the final product. It uses Computer Aided Design (CAD) i.e. a digital blueprint to create rapid prototypes, spare parts and final products. 3D printing uses materials like thermoplastics, plastic composites, metals, alloys, ceramics etc. 3D printing as an end-use manufacturing technology is still not fully developed but it has the potential to transform the conception, manufacturing and logistics processes.
The global 3D Bioprinting for Life Science R&D market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The drug testing market is likely to be the main driver of the 3D Bioprinting for Life Science R&D Market. Since 2011, a group of U.S government agencies have been investing in something known as ‘Human on a chip’ or ‘Body on a chip’. The objective is to create a miniature human organ system that mimics the bodily response to harmful agents, enabling the development of potential therapies. The pharmaceutical industry could use such equipment to test drugs more efficiently due to human stem cells and at a much lower cost. It would also be less risky.
This report aims to provide a comprehensive presentation of the global market for 3D Bioprinting for Life Science R&D, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Bioprinting for Life Science R&D.
Report Scope
The 3D Bioprinting for Life Science R&D market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global 3D Bioprinting for Life Science R&D market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 3D Bioprinting for Life Science R&D companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
EnvisionTEC
Regenovo
Organovo
3D Systems
3D Biotek
Advanced Biomatrix
Digilab
Nano3D Biosciences
Segment by Type
Magnetic 3D Bioprinting
Laser-Assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Segment by Application
Clinical
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 3D Bioprinting for Life Science R&D companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global 3D Bioprinting for Life Science R&D Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Magnetic 3D Bioprinting
1.2.3 Laser-Assisted Bioprinting
1.2.4 Inkjet 3D Bioprinting
1.2.5 Microextrusion 3D Bioprinting
1.3 Market by Application
1.3.1 Global 3D Bioprinting for Life Science R&D Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global 3D Bioprinting for Life Science R&D Market Perspective (2019-2030)
2.2 3D Bioprinting for Life Science R&D Growth Trends by Region
2.2.1 Global 3D Bioprinting for Life Science R&D Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 3D Bioprinting for Life Science R&D Historic Market Size by Region (2019-2024)
2.2.3 3D Bioprinting for Life Science R&D Forecasted Market Size by Region (2025-2030)
2.3 3D Bioprinting for Life Science R&D Market Dynamics
2.3.1 3D Bioprinting for Life Science R&D Industry Trends
2.3.2 3D Bioprinting for Life Science R&D Market Drivers
2.3.3 3D Bioprinting for Life Science R&D Market Challenges
2.3.4 3D Bioprinting for Life Science R&D Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top 3D Bioprinting for Life Science R&D Players by Revenue
3.1.1 Global Top 3D Bioprinting for Life Science R&D Players by Revenue (2019-2024)
3.1.2 Global 3D Bioprinting for Life Science R&D Revenue Market Share by Players (2019-2024)
3.2 Global 3D Bioprinting for Life Science R&D Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by 3D Bioprinting for Life Science R&D Revenue
3.4 Global 3D Bioprinting for Life Science R&D Market Concentration Ratio
3.4.1 Global 3D Bioprinting for Life Science R&D Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by 3D Bioprinting for Life Science R&D Revenue in 2023
3.5 3D Bioprinting for Life Science R&D Key Players Head office and Area Served
3.6 Key Players 3D Bioprinting for Life Science R&D Product Solution and Service
3.7 Date of Enter into 3D Bioprinting for Life Science R&D Market
3.8 Mergers & Acquisitions, Expansion Plans
4 3D Bioprinting for Life Science R&D Breakdown Data by Type
4.1 Global 3D Bioprinting for Life Science R&D Historic Market Size by Type (2019-2024)
4.2 Global 3D Bioprinting for Life Science R&D Forecasted Market Size by Type (2025-2030)
5 3D Bioprinting for Life Science R&D Breakdown Data by Application
5.1 Global 3D Bioprinting for Life Science R&D Historic Market Size by Application (2019-2024)
5.2 Global 3D Bioprinting for Life Science R&D Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America 3D Bioprinting for Life Science R&D Market Size (2019-2030)
6.2 North America 3D Bioprinting for Life Science R&D Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America 3D Bioprinting for Life Science R&D Market Size by Country (2019-2024)
6.4 North America 3D Bioprinting for Life Science R&D Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe 3D Bioprinting for Life Science R&D Market Size (2019-2030)
7.2 Europe 3D Bioprinting for Life Science R&D Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe 3D Bioprinting for Life Science R&D Market Size by Country (2019-2024)
7.4 Europe 3D Bioprinting for Life Science R&D Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific 3D Bioprinting for Life Science R&D Market Size (2019-2030)
8.2 Asia-Pacific 3D Bioprinting for Life Science R&D Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific 3D Bioprinting for Life Science R&D Market Size by Region (2019-2024)
8.4 Asia-Pacific 3D Bioprinting for Life Science R&D Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America 3D Bioprinting for Life Science R&D Market Size (2019-2030)
9.2 Latin America 3D Bioprinting for Life Science R&D Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America 3D Bioprinting for Life Science R&D Market Size by Country (2019-2024)
9.4 Latin America 3D Bioprinting for Life Science R&D Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa 3D Bioprinting for Life Science R&D Market Size (2019-2030)
10.2 Middle East & Africa 3D Bioprinting for Life Science R&D Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa 3D Bioprinting for Life Science R&D Market Size by Country (2019-2024)
10.4 Middle East & Africa 3D Bioprinting for Life Science R&D Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 EnvisionTEC
11.1.1 EnvisionTEC Company Detail
11.1.2 EnvisionTEC Business Overview
11.1.3 EnvisionTEC 3D Bioprinting for Life Science R&D Introduction
11.1.4 EnvisionTEC Revenue in 3D Bioprinting for Life Science R&D Business (2019-2024)
11.1.5 EnvisionTEC Recent Development
11.2 Regenovo
11.2.1 Regenovo Company Detail
11.2.2 Regenovo Business Overview
11.2.3 Regenovo 3D Bioprinting for Life Science R&D Introduction
11.2.4 Regenovo Revenue in 3D Bioprinting for Life Science R&D Business (2019-2024)
11.2.5 Regenovo Recent Development
11.3 Organovo
11.3.1 Organovo Company Detail
11.3.2 Organovo Business Overview
11.3.3 Organovo 3D Bioprinting for Life Science R&D Introduction
11.3.4 Organovo Revenue in 3D Bioprinting for Life Science R&D Business (2019-2024)
11.3.5 Organovo Recent Development
11.4 3D Systems
11.4.1 3D Systems Company Detail
11.4.2 3D Systems Business Overview
11.4.3 3D Systems 3D Bioprinting for Life Science R&D Introduction
11.4.4 3D Systems Revenue in 3D Bioprinting for Life Science R&D Business (2019-2024)
11.4.5 3D Systems Recent Development
11.5 3D Biotek
11.5.1 3D Biotek Company Detail
11.5.2 3D Biotek Business Overview
11.5.3 3D Biotek 3D Bioprinting for Life Science R&D Introduction
11.5.4 3D Biotek Revenue in 3D Bioprinting for Life Science R&D Business (2019-2024)
11.5.5 3D Biotek Recent Development
11.6 Advanced Biomatrix
11.6.1 Advanced Biomatrix Company Detail
11.6.2 Advanced Biomatrix Business Overview
11.6.3 Advanced Biomatrix 3D Bioprinting for Life Science R&D Introduction
11.6.4 Advanced Biomatrix Revenue in 3D Bioprinting for Life Science R&D Business (2019-2024)
11.6.5 Advanced Biomatrix Recent Development
11.7 Digilab
11.7.1 Digilab Company Detail
11.7.2 Digilab Business Overview
11.7.3 Digilab 3D Bioprinting for Life Science R&D Introduction
11.7.4 Digilab Revenue in 3D Bioprinting for Life Science R&D Business (2019-2024)
11.7.5 Digilab Recent Development
11.8 Nano3D Biosciences
11.8.1 Nano3D Biosciences Company Detail
11.8.2 Nano3D Biosciences Business Overview
11.8.3 Nano3D Biosciences 3D Bioprinting for Life Science R&D Introduction
11.8.4 Nano3D Biosciences Revenue in 3D Bioprinting for Life Science R&D Business (2019-2024)
11.8.5 Nano3D Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
